The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment
Status:
Recruiting
Trial end date:
2021-01-30
Target enrollment:
Participant gender:
Summary
This study is designed to observed prospectively the efficacy and safety of 6 months and
long-term treatment of Tacrolimus alone or with methotrexate (MTX) in moderate and severe
Chinese RA patients who shown insufficiency response or intolerance to DMARDs